Enovis Corp. (ENOV)
18.56
-0.84
(-4.33%)
USD |
NYSE |
Sep 04, 16:00
18.66
+0.10
(+0.54%)
Pre-Market: 20:00
Enovis SG&A Expense (TTM) : 1.081B for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.081B |
| March 31, 2026 | 1.084B |
| December 31, 2025 | 1.070B |
| September 30, 2025 | 1.057B |
| June 30, 2025 | 1.044B |
| March 31, 2025 | 1.041B |
| December 31, 2024 | 1.027B |
| September 30, 2024 | 980.66M |
| June 30, 2024 | 935.05M |
| March 31, 2024 | 878.83M |
| December 31, 2023 | 830.30M |
| September 30, 2023 | 827.88M |
| June 30, 2023 | 805.82M |
| March 31, 2023 | 823.42M |
| December 31, 2022 | 804.74M |
| September 30, 2022 | 774.70M |
| June 30, 2022 | 760.79M |
| March 31, 2022 | 733.22M |
| December 31, 2021 | 850.46M |
| September 30, 2021 | 953.32M |
| June 30, 2021 | 1.063B |
| March 31, 2021 | 1.101B |
| December 31, 2020 | 1.087B |
| September 30, 2020 | 1.091B |
| June 30, 2020 | 1.103B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.176B |
| December 31, 2019 | 1.132B |
| September 30, 2019 | 991.68M |
| June 30, 2019 | 830.74M |
| March 31, 2019 | 658.75M |
| December 31, 2018 | 611.42M |
| September 30, 2018 | 664.82M |
| June 30, 2018 | 717.09M |
| March 31, 2018 | 758.03M |
| December 31, 2017 | 732.34M |
| September 30, 2017 | 703.38M |
| June 30, 2017 | 689.39M |
| March 31, 2017 | 726.06M |
| December 31, 2016 | 765.62M |
| September 30, 2016 | 828.63M |
| June 30, 2016 | 898.03M |
| March 31, 2016 | 907.11M |
| December 31, 2015 | 905.95M |
| September 30, 2015 | 928.23M |
| June 30, 2015 | 936.42M |
| March 31, 2015 | 992.82M |
| December 31, 2014 | 1.011B |
| September 30, 2014 | 975.21M |
| June 30, 2014 | 937.90M |
| March 31, 2014 | 880.10M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intuitive Surgical, Inc. | 2.492B |
| STAAR Surgical Co. | 180.87M |
| Inspire Medical Systems, Inc. | 620.30M |
| Edwards Lifesciences Corp. | 2.201B |
| Kewaunee Scientific Corp. | 63.72M |